NeuroSense Therapeutics Ltd. (NRSN): Total Assets
$1.03M
As of 2025-12-31
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.03M | -77.5% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $4.58M | +43.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $3.19M | n/a | 2025-04-07, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| NeuroSense Therapeutics Ltd. (NRSN) | 2025-12-31 | $1.03M | -77.5% |
| Ocean Biomedical, Inc. (OCEA) | 2024-12-31 | $902.0K | -83.6% |
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | $1.31M | +786.7% |
| Semnur Pharmaceuticals, Inc. (SMNR) | 2025-12-31 | $1.35M | -79.9% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $697.5K | -30.7% |
| Accustem Sciences Inc. (ACUT) | 2025-12-31 | $1.55M | n/m |
| Bioxytran, Inc (BIXT) | 2025-12-31 | $658.6K | +374.8% |
| Alzamend Neuro, Inc. (ALZN) | 2026-04-30 | $2.08M | -54.8% |
| ProtoKinetix, Inc. (PKTX) | 2025-12-31 | $483.4K | +3.7% |
Compare NRSN, OCEA, ASBP, SMNR side by side · Screen every company in Pharmaceutical Preparations ↗